SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck
MRK 108.83-1.9%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LWolf who wrote (604)3/5/1998 7:41:00 PM
From: LWolf  Read Replies (1) of 1580
 
To all: Merck says FDA gives Crixivan approval

NEW YORK, March 5 (Reuters) - Merck & Co said the U.S. Food and Drug Administration had granted final approval of its HIV protease
inhibitor, Crixivan, based on two studies showing it prevented death and AIDS-related symptoms in combination therapy with antiretroviral
drugs.

biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext